Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-22

Clinical Trial Update: The Effect of Topical Imipramine on Photodynamic Therapy-Mediated Immunosuppression on Forearms or Face on US Veterans [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating whether topical imipramine can influence photodynamic therapy-mediated immunosuppression in actinic keratosis lesions on the forea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Imipramine (imipramine)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Actinic Keratosis, Imipramine | Phase 2 | Status: RECRUITING